Showing 20 of 136 recruiting trials for “hepatocellular-adenoma”
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
RecruitingNCT06746194 ↗
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Enrolling by InvitationNCT06624189 ↗
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
RecruitingNCT06813508 ↗
Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
👨⚕️ Fabio Piscaglia, Prof, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Nov 2024View details ↗
Mts105 for Advanced Hepatocellular Carcinoma
Needle-based Percutaneous Ablation of Liver Tumors.
Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation
👨⚕️ Francesco Vasuri, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Oct 2024View details ↗
DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
RecruitingNCT06569498 ↗
Neoadjuvant Triple Therapy for Resectable HCC
RecruitingNCT06602011 ↗
Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
RecruitingNCT06777628 ↗
Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma
👨⚕️ Laura Gramantieri, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Sep 2024View details ↗
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
RecruitingNCT07303712 ↗
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Phase 2 Study of WGI-0301 for Advanced HCC
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
👨⚕️ Eric Roeland, M.D., FAAHPM, FASCO, OHSU Knight Cancer Institute📍 1 site📅 Started Jul 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →